Targeting Angiogenesis for Advanced Hepatocellular Carcinoma

被引：1

作者：

Eso, Yuji ^{[1
]}

机构：

[1] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan

来源：

INTERNAL MEDICINE | 2021年 / 60卷 / 03期

关键词：

angiogenesis; hepatocellular carcinoma; immune checkpoint inhibitor; immunotherapy; molecular targeted therapy; vascular endothelial growth factor; SORAFENIB;

D O I：

10.2169/internalmedicine.5923-20

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：321 / 322

页数：2

共 15 条

[1] TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection [J].

Alfei, Francesca ;

Kanev, Kristiyan ;

Hofmann, Maike ;

Wu, Ming ;

Ghoneim, Hazem E. ;

Roelli, Patrick ;

Utzschneider, Daniel T. ;

von Hoesslin, Madlaina ;

Cullen, Jolie G. ;

Fan, Yiping ;

Eisenberg, Vasyl ;

Wohlleber, Dirk ;

Steiger, Katja ;

Merkler, Doron ;

Delorenzi, Mauro ;

Knolle, Percy A. ;

Cohen, Cyrille J. ;

Thimme, Robert ;

Youngblood, Benjamin ;

Zehn, Dietmar .

NATURE, 2019, 571 (7764) :265-+

[2] Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial [J].

Bruix, Jordi ;

Qin, Shukui ;

Merle, Philippe ;

Granito, Alessandro ;

Huang, Yi-Hsiang ;

Bodoky, Gyrogy ;

Pracht, Marc ;

Yokosuka, Osamu ;

Rosmorduc, Olivier ;

Breder, Valeriy ;

Gerolami, Rene ;

Masi, Gianluca ;

Ross, Paul J. ;

Song, Tianqiang ;

Bronowicki, Jean-Pierre ;

Ollivier-Hourmand, Isabelle ;

Kudo, Masatoshi ;

Cheng, Ann-Lii ;

Llovet, Josep M. ;

Finn, Richard S. ;

LeBerre, Marie-Aude ;

Baumhauer, Annette ;

Meinhardt, Gerold ;

Han, Guohong .

LANCET, 2017, 389 (10064) :56-66

[3]

Eso Y, CANCERS BASEL, V12, P49

[4] Novel approaches for molecular targeted therapy against hepatocellular carcinoma [J].

Eso, Yuji ;

Marusawa, Hiroyuki .

HEPATOLOGY RESEARCH, 2018, 48 (08) :597-607

[5] Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma [J].

Finn, Richard S. ;

Qin, Shukui ;

Ikeda, Masafumi ;

Galle, Peter R. ;

Ducreux, Michel ;

Kim, Tae-You ;

Kudo, Masatoshi ;

Breder, Valeriy ;

Merle, Philippe ;

Kaseb, Ahmed O. ;

Li, Daneng ;

Verret, Wendy ;

Xu, Derek-Zhen ;

Hernandez, Sairy ;

Liu, Juan ;

Huang, Chen ;

Mulla, Sohail ;

Wang, Yulei ;

Lim, Ho Yeong ;

Zhu, Andrew X. ;

Cheng, Ann-Lii .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20) :1894-1905

[6] Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges [J].

Fukurnura, Dal ;

Kloepper, Jonas ;

Amoozgar, Zohreh ;

Duda, Dan G. ;

Jain, Rakesh K. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (05) :325-340

[7] Efficacy and Safety of Ramucirumab in Patients with Unresectable Hepatocellular Carcinoma with Progression after Treatment with Lenvatinib [J].

Kasuya, Kayoko ;

Kawamura, Yusuke ;

Kobayashi, Masahiro ;

Shindoh, Junichi ;

Kobayashi, Yuta ;

Kajiwara, Akira ;

Iritani, Soichi ;

Fujiyama, Shunichiro ;

Hosaka, Tetsuya ;

Saitoh, Satoshi ;

Sezaki, Hitomi ;

Akuta, Norio ;

Suzuki, Fumitaka ;

Suzuki, Yoshiyuki ;

Ikeda, Kenji ;

Arase, Yasuji ;

Eguchi, Yuichiro ;

Hashimoto, Masaji ;

Kumada, Hiromitsu .

INTERNAL MEDICINE, 2021, 60 (03) :345-351

[8] TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion [J].

Khan, Omar ;

Giles, Josephine R. ;

McDonald, Sierra ;

Manne, Sasikanth ;

Ngiow, Shin Foong ;

Patel, Kunal P. ;

Werner, Michael T. ;

Huang, Alexander C. ;

Alexander, Katherine A. ;

Wu, Jennifer E. ;

Attanasio, John ;

Yan, Patrick ;

George, Sangeeth M. ;

Bengsch, Bertram ;

Staupe, Ryan P. ;

Donahue, Greg ;

Xu, Wei ;

Amaravadi, Ravi K. ;

Xu, Xiaowei ;

Karakousis, Giorgos C. ;

Mitchell, Tara C. ;

Schuchter, Lynn M. ;

Kaye, Jonathan ;

Berger, Shelley L. ;

Wherry, E. John .

NATURE, 2019, 571 (7764) :211-+

[9] VEGF-A drives TOX-dependent T cell exhaustion in anti-PD-1-resistant microsatellite stable colorectal cancers [J].

Kim, Chang Gon ;

Jang, Mi ;

Kim, Youngun ;

Leem, Galam ;

Kim, Kyung Hwan ;

Lee, Hoyoung ;

Kim, Tae-Shin ;

Choi, Seong Jin ;

Kim, Hyung-Don ;

Han, Ji Won ;

Kwon, Minsuk ;

Kim, Jong Hoon ;

Lee, Andrew J. ;

Nam, Su Kyung ;

Bae, Seok-Joo ;

Lee, Sat Byol ;

Shin, Sang Joon ;

Park, Sung Ho ;

Ahn, Joong Bae ;

Jung, Inkyung ;

Lee, Kang Young ;

Park, Su-Hyung ;

Kim, Hoguen ;

Min, Byung Soh ;

Shin, Eui-Cheol .

SCIENCE IMMUNOLOGY, 2019, 4 (41)

[10] Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial [J].

Kudo, Masatoshi ;

Finn, Richard S. ;

Qin, Shukui ;

Han, Kwang-Hyub ;

Ikeda, Kenji ;

Piscaglia, Fabio ;

Baron, Ari ;

Park, Joong-Won ;

Han, Guohong ;

Jassem, Jacek ;

Blanc, Jean Frederic ;

Vogel, Arndt ;

Komov, Dmitry ;

Evans, T. R. Jeffry ;

Lopez, Carlos ;

Dutcus, Corina ;

Guo, Matthew ;

Saito, Kenichi ;

Kraljevic, Silvija ;

Tamai, Toshiyuki ;

Ren, Min ;

Cheng, Ann-Lii .

LANCET, 2018, 391 (10126) :1163-1173

← 1 2 →